Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Mertens

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Haematologica|October 6, 2011
Chronic lymphocytic leukemia--genomics lead the wayDaniel Mertens, Lars Bullinger, Stephan Stilgenbauer
F1000Prime Reports|August 29, 2014
Advances in treating chronic lymphocytic leukemiaEugen Tausch, Daniel Mertens, Stephan Stilgenbauer
Expert Opinion on Pharmacotherapy|November 22, 2011
Treating chronic lymphocytic leukemia with thalidomide and lenalidomideKrzysztof Giannopoulos, Daniel Mertens, Stephan Stilgenbauer
Haematologica|September 3, 2010
Biological diversity and risk-adapted treatment of chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Stephan Stilgenbauer
Cancers|January 8, 2023
To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?Karol D Urbanek, Stephan Stilgenbauer, Daniel Mertens
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
In vivo processing assay based on a dual-luciferase reporter system to evaluate DROSHA enzymatic activityVera Bilan, Danilo Allegra, Florian Kuchenbauer, et al.
Leukemia & Lymphoma|May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implicationsThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Blood Reviews|March 26, 2011
Importance of genetics in chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Genomics|March 1, 2006
Functional screening for proapoptotic genes by reverse transfection cell array technologyOtto Mannherz, Daniel Mertens, Meinhard Hahn, et al.
Leukemia & Lymphoma|January 18, 2013
Missing the notch in NOTCH1Sabrina J Kugler, Andrea Schnaiter, Stephan Stilgenbauer, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Haematologica|October 6, 2011
Chronic lymphocytic leukemia--genomics lead the wayDaniel Mertens, Lars Bullinger, Stephan Stilgenbauer
F1000Prime Reports|August 29, 2014
Advances in treating chronic lymphocytic leukemiaEugen Tausch, Daniel Mertens, Stephan Stilgenbauer
Expert Opinion on Pharmacotherapy|November 22, 2011
Treating chronic lymphocytic leukemia with thalidomide and lenalidomideKrzysztof Giannopoulos, Daniel Mertens, Stephan Stilgenbauer
Haematologica|September 3, 2010
Biological diversity and risk-adapted treatment of chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Stephan Stilgenbauer
Cancers|January 8, 2023
To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?Karol D Urbanek, Stephan Stilgenbauer, Daniel Mertens
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
In vivo processing assay based on a dual-luciferase reporter system to evaluate DROSHA enzymatic activityVera Bilan, Danilo Allegra, Florian Kuchenbauer, et al.
Leukemia & Lymphoma|May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implicationsThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Blood Reviews|March 26, 2011
Importance of genetics in chronic lymphocytic leukemiaThorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Genomics|March 1, 2006
Functional screening for proapoptotic genes by reverse transfection cell array technologyOtto Mannherz, Daniel Mertens, Meinhard Hahn, et al.
Leukemia & Lymphoma|January 18, 2013
Missing the notch in NOTCH1Sabrina J Kugler, Andrea Schnaiter, Stephan Stilgenbauer, et al.
Pageof 10